Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1983-10-05
1985-08-27
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514210, 514770, A61K 3143, A61K 3142, A61K 4700
Patent
active
045378878
ABSTRACT:
A unit dose pharmaceutical composition suitable for oral administration which composition comprises a pharmaceutically acceptable carrier, a desiccant, amoxycillin trihydrate equivalent to 20 mg to 1500 mg of amoxycillin and potassium clavulanate equivalent to 20 mg to 500 mg of clavulanic acid, with the proviso that the weight ratio of amoxycillin to clavulanic acid is in the range 12:1 to 1:1; characterized in that the composition is in tablet form, wherein the desiccant is edible and incorporated within the tablets.
REFERENCES:
patent: 4140755 (1979-02-01), Sheth et al.
patent: 4226849 (1980-10-01), Schor
patent: 4282202 (1981-08-01), Dowrick
Burnstead Barry W.
Rooke David J.
Beecham Group Limited
Rollins John W.
Waddell Frederick E.
LandOfFree
Pharmaceutical formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2001825